Hepatitis C Virus Nucleocapsid Genotype-2a (HCV N) (AA 2322-2423) peptide (GST tag)
Kurzübersicht für Hepatitis C Virus Nucleocapsid Genotype-2a (HCV N) (AA 2322-2423) peptide (GST tag) (ABIN935423)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Recombinant
-
Protein Region
- AA 2322-2423
-
Aufreinigungstag / Konjugat
- Dieses HCV Nucleocapsid Genotype 2a Peptid ist gelabelt mit GST tag.
-
Produktmerkmale
-
Hepatitis C Virus Core Genotype-2 a recombinant protein
Expression System: E.coli -
Aufreinigung
- Proprietary chromatographic technique
-
Reinheit
- > 95 % pure
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- 50 mM Tris, pH 8.0 and 0 mM EDTA.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- RT/-20 °C
-
-
- HCV Nucleocapsid Genotype 2a (HCV N) (Hepatitis C Virus Nucleocapsid Genotype-2a (HCV N))
-
Substanzklasse
- Viral Protein
-
Hintergrund
-
HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae. HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes(1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6).
Alternative Names: Hepatitis C protein, HCV Recombinant protein, Hep C protein, HCV protein, HCV Nucleocpasid Genotype 2a protein -
Molekulargewicht
- 38.34 kDa
Target
-